Literature DB >> 3379674

The relationship of sibling reflux to index patient dysfunctional voiding.

H N Noe1.   

Abstract

The rate of sibling reflux in index patients with and without dysfunctional voiding symptoms was compared. Of the siblings of index patients with reflux and dysfunctional voiding 20 per cent demonstrated reflux compared to 38 per cent of siblings of those without symptom of bladder dysfunction. The difference is significant and suggests an interaction of genetic and environmental factors. These factors are discussed. There remains a need to screen siblings of patients with reflux regardless of symptoms of either the index patient or the sibling.

Entities:  

Mesh:

Year:  1988        PMID: 3379674     DOI: 10.1016/s0022-5347(17)41502-3

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  5 in total

1.  Vesicoureteric reflux and renal scars in asymptomatic siblings of children with reflux.

Authors:  R B Kenda; J J Fettich
Journal:  Arch Dis Child       Date:  1992-04       Impact factor: 3.791

Review 2.  Dysfunctional voiding syndromes and vesicoureteral reflux.

Authors:  Y L Homsy
Journal:  Pediatr Nephrol       Date:  1994-02       Impact factor: 3.714

3.  Vesicoureteric reflux deterioration in monozygotic twins.

Authors:  Spyridon Tsiouris; Chrissa Sioka; Anna Marinarou; Jihad Al-Bokharhli; Irene Sionti; Andreas Fotopoulos
Journal:  Indian J Pediatr       Date:  2008-03       Impact factor: 1.967

4.  Screening for vesicoureteral reflux and renal scars in siblings of children with known reflux.

Authors:  Neamatollah Ataei; Abbas Madani; Seyed Taher Esfahani; Abdolmohammad Kejbafzadeh; Omid Ghaderi; Said Jalili; Bita Sharafi
Journal:  Pediatr Nephrol       Date:  2004-08-12       Impact factor: 3.714

5.  Incidence of Urinary Tract Infection Among Siblings of Children With Vesicoureteral Reflux.

Authors:  Caleb P Nelson; Jonathan A Finkelstein; Tanya Logvinenko; Mark A Schuster
Journal:  Acad Pediatr       Date:  2015-11-14       Impact factor: 3.107

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.